Carcinosarcoma of the ovary: a review of the literature (Q37966609)

26 August 2017

Carcinosarcoma of the ovary: a review of the literature (English)

1 reference

26 August 2017

Marcela G del Carmen

1

1 reference

26 August 2017

Michael Birrer

series ordinal

2

1 reference

26 August 2017

John O Schorge

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

8 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

125

1 reference

26 August 2017

1

1 reference

26 August 2017

271-277

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Current management of ovarian carcinosarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

The Immunohistochemical Profile of Malignant Mixed Mullerian Tumor: Overlap with Endometrial Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed mullerian tumour of the ovary: Prognostic factor and response of adjuvant platinum‐based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcomas (Malignant Mullerian Mixed Tumors) of the Uterus and Ovary: A Genetic Study With Special Reference to Histogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Two cell lines established from mixed Müllerian tumors of the uterus morphologic, immunocytochemical, and cytogenetic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary-a case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed müllerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Chemotherapy for malignant mixed Müllerian tumors of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Clinicopathological features of ovarian carcinosarcomas: a single institution experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

Morphologic prognostic factors of malignant mixed müllerian tumors of the ovary: a clinicopathologic study of 15 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.418

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2011.12.418

1 reference

26 August 2017

1 reference